Nauck, M A <br/><br/>
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.  [electronic resource] 

 -  The Journal of clinical investigation  Jan 1993 
 - 301-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0021-9738 
<br/><br/><label>Standard No.: </label>10.1172/JCI116186  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blood Glucose--metabolism<br/>C-Peptide--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Female<br/>Gastric Inhibitory Polypeptide--blood<br/>Glucagon--blood<br/>Glucagon-Like Peptide 1<br/>Glucagon-Like Peptides<br/>Glucose Clamp Technique<br/>Glycated Hemoglobin--analysis<br/>Humans<br/>Insulin--blood<br/>Insulin Secretion<br/>Kinetics<br/>Male<br/>Middle Aged<br/>Peptide Fragments--blood<br/>Protein Precursors--blood<br/>Reference Values<br/>Time Factors